Related Experiment Videos
Gentamicin interval in newborn infants as determined by renal function and postconceptional age
L P Brion1, A R Fleischman, G J Schwartz
1Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York 10461.
Insights
Gentamicin dosing intervals for neonates with kidney problems can be estimated using plasma creatinine levels. This helps optimize gentamicin therapy and minimize toxicity in infants with renal insufficiency.
Area of Science:
- Neonatal pharmacokinetics
- Pediatric nephrology
- Antibiotic dosing
Background:
- Gentamicin is a critical antibiotic for neonatal infections.
- Renal insufficiency in neonates complicates gentamicin dosing.
- Accurate dosing is essential to balance efficacy and toxicity.
Purpose of the Study:
- To evaluate the relationship between gentamicin pharmacokinetics and glomerular filtration rate in neonates.
- To establish appropriate gentamicin administration intervals for neonates with renal insufficiency.
Main Methods:
- Multiple regression analysis correlating gentamicin half-life (Gt1/2) with plasma creatinine concentration (PCr).
- Inclusion of post-conceptional age in regression models.
- Comparison of gentamicin levels in infants based on PCr thresholds.
Main Results:
- Gentamicin half-life (Gt1/2) significantly predicted by plasma creatinine concentration (PCr) (r = 0.78).
- Prediction accuracy improved slightly with post-conceptional age (r = 0.81).
- Infants with higher PCr (≥1 mg/dl) and post-conceptional age (≥29 weeks) had higher gentamicin levels.
Conclusions:
- Gentamicin administration interval in neonates with renal insufficiency should be 2-3 Gt1/2.
- Estimated Gt1/2 = 2.0 + 7.7 PCr provides a basis for interval calculation.
- Dosing intervals require adjustment based on measured peak and trough gentamicin levels.
Abstract:
We evaluated the relationship between gentamicin pharmacokinetics and glomerular filtration rate in newborn infants to estimate the appropriate interval of administration in neonates with renal insufficiency. Gentamicin half-life (Gt1/2) could be predicted from plasma creatinine concentration (PCr) (r = 0.78); the prediction was minimally but significantly increased (r = 0.81) by adding post-conceptional age to a multiple regression analysis. Infants with a postconceptional age of 29 weeks or more and a PCr of 1 mg/dl or more had significantly greater through and peak gentamicin levels than those with a PCr less than 1 mg/dl. If gentamicin is indicated in a patient with renal insufficiency, the interval of administration should be 2-3 Gt1/2, which can be estimated from PCr (Gt1/2 = 2.0 + 7.7 PCr). The interval can then be adjusted according to peak and trough gentamicin levels.